We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
-19.94%
1 Year Est. Return
+35.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$74M
AUM Growth
-$32.8M
Cap. Flow
-$14M
Cap. Flow %
-18.88%
Top 10 Hldgs %
57.13%
Holding
106
New
12
Increased
9
Reduced
42
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 21.3%
2 Financials 18.15%
3 Consumer Discretionary 9.23%
4 Communication Services 8.92%
5 Technology 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTLA icon
76
Intellia Therapeutics
NTLA
$1.67B
-12,530
Closed -$359K
ORCL icon
77
Oracle
ORCL
$423B
-14,716
Closed -$759K
PBYI icon
78
Puma Biotechnology
PBYI
$454M
-15,035
Closed -$689K
PTEN icon
79
Patterson-UTI
PTEN
$3.76B
-17,867
Closed -$306K
PYPL icon
80
PayPal
PYPL
$50.5B
-4,000
Closed -$351K
PZZA icon
81
Papa John's
PZZA
$806M
-27,500
Closed -$1.41M
SAN icon
82
Banco Santander
SAN
$210B
-14,130
Closed -$68K
SPY icon
83
State Street SPDR S&P 500 ETF Trust
SPY
$810B
-5,508
Closed -$1.6M
TGTX icon
84
TG Therapeutics
TGTX
$7.62B
-12,528
Closed -$70K
TRGP icon
85
Targa Resources
TRGP
$55.1B
-13,944
Closed -$785K
UTHR icon
86
United Therapeutics
UTHR
$23.1B
-2,506
Closed -$320K
VTRS icon
87
Viatris
VTRS
$18.9B
-7,000
Closed -$256K
XLF icon
88
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
-40,000
Closed -$1.1M
SYRS
89
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-1,327
Closed -$158K
VIRX
90
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-1,000
Closed -$70K
AAMC
91
DELISTED
Altisource Asset Management Corp
AAMC
-8,529
Closed -$300K
DCPH
92
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-7,000
Closed -$271K
PXD
93
DELISTED
Pioneer Natural Resource Co.
PXD
-2,144
Closed -$373K
ACOR
94
DELISTED
Acorda Therapeutics
ACOR
-120
Closed -$284K
SIOX
95
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-3,915
Closed -$76K
SRRA
96
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-2,957
Closed -$201K
ARNA
97
DELISTED
Arena Pharmaceuticals Inc
ARNA
-7,000
Closed -$322K
CXO
98
DELISTED
CONCHO RESOURCES INC.
CXO
-2,949
Closed -$450K
PE
99
DELISTED
PARSLEY ENERGY INC
PE
-11,881
Closed -$348K
NBL
100
DELISTED
Noble Energy, Inc.
NBL
-12,864
Closed -$401K

Similar funds

Kazazian Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Kazazian Asset Management held 106 positions worth $74M, down 31% from $107M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Kazazian Asset Management withdrew a net $14M in Q4 2018, closing 42 positions and reducing 42 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kazazian Asset Management opened a new position in iShares Russell 2000 ETF worth $6.64M.

  • Kazazian Asset Management's largest Q4 2018 buy was iShares Russell 2000 ETF: 49,629 shares worth $6.64M.
  • Kazazian Asset Management added most to Apple in Q4 2018, an estimated $3.22M increase.
  • Kazazian Asset Management's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $8.03M.
  • Kazazian Asset Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2018, selling an estimated $1.6M.
  • Kazazian Asset Management's ten largest holdings make up 57% of its $74M portfolio in Q4 2018.
  • Kazazian Asset Management opened 12 new positions and closed 42 in Q4 2018.
  • Kazazian Asset Management's portfolio value fell 31% quarter-over-quarter to $74M.

Based on Kazazian Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.